Refractory asthma: mechanisms, targets, and therapy
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Asthma is a common medical condition affecting 300 million people worldwide. Airway inflammation, smooth muscle bronchoconstriction leading to airflow obstruction, and mucous hypersecretion are clinical hallmarks of asthma. The NHLBI Expert Panel Report 3 recommends inhaled corticosteroids (ICS) for patients with moderate to severe persistent asthma. Inhaled corticosteroids (ICS) target gene transcription through their interactions with the glucocorticoid (GC) receptor (GR) at the glucocorticoid response element (GRE). The GC/GR complex enhances anti‐inflammatory but inhibits pro‐inflammatory mediator production. Classically, asthma has been described as a Th2‐associated eosinophil‐predominant disease, but recently alternative models have been described including a Th17‐mediated neutrophil‐predominant phenotype resulting in patients with more severe disease who may be less responsive to steroids. Additional mechanisms of steroid resistance include increased activity of GR phosphorylating kinases which modify the interactions of GR with transcription factors to inhibit the ability of GR to bind with GRE, leading to an increase in pro‐inflammatory gene transcription. Oxidative stress also affects the balance between pro‐inflammatory and anti‐inflammatory gene transcription through the modification of transcription factors and cofactors (such as PI 3K) leading to the inhibition of histone deacetylase 2. Continued investigations into the mechanisms behind glucocorticoid resistance will lead to novel treatments that improve control of severe refractory asthma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
Rhen, T., & Cidlowski, J. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050541 · Cited by 3,149 · cited 1×
“The latter two work as anti-inflammatory proteins with MKP-1 functioning as an inhibitor of MAPK pathways which promote the transcription of pro-inflammatory genes (43, 45).”
Background(2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.09.029 · Cited by 2,181
The cytokine network in asthma and chronic obstructive pulmonary disease
Barnes, P. J. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36130 · Cited by 982 · cited 2×
“Th2 lymphocytes also produce IL-9 which stimulates mast cell proliferation in the airway (8), and IL-5, a cytokine associated with eosinophil survival (6).”
BackgroundIto, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638
The human glucocorticoid receptor: molecular basis of biologic function
Nicolaides, N. C., Galata, Z., Kino, T., Chrousos, G. P., & Charmandari, E. (2010) · Steroids · doi:10.1016/j.steroids.2009.09.002 · Cited by 436 · cited 1×
“Once bound, conformational changes occur that result in the release of nuclear chaperone proteins such as heat shock protein 90 (hsp-90) exposing two nuclear localization sequences (NL1 and NL2) on GR (44), allowing it to”
BackgroundIL-33 promotes airway remodeling in pediatric patients with severe steroid-resistant asthma
Saglani, S., Lui, S., Ullmann, N., Campbell, G. A., Sherburn, R. T., Mathie, S. A., Denney, L., Bossley, C. J., Oates, T., Walker, S. A., et al. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.04.012 · Cited by 258 · cited 1×
“The action of IL-33 is unaffected by exposure to high-dose steroids, suggesting that this interleukin plays an important role in the pathogenesis of steroid-resistant asthma (41).”
Background
Cited by
Severe and Difficult-to-Treat Asthma in Adults
Israel, E., & Reddel, H. K. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1608969 · Cited by 474
Zhu, T., Wu, X.-L., Zhang, W., & Xiao, M. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160920195 · Cited by 106
“Several studies figured out that the majority of airways of fatal asthmatic individuals were blocked by the gelatinous substance composed of mucus and inflammatory exudates [4,6,7].”
BackgroundSleep deprivation predisposes allergic mice to neutrophilic lung inflammation
Nunes, J. O. F., Apostolico, J. D. S., Andrade, D. A. G., Ruiz, F. S., Fernandes, E. R., Andersen, M. L., Keller, A. C., & Rosa, D. S. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2017.06.025 · Cited by 43
Porter, K. N., Sarkar, S. N., Dakhlallah, D. A., Vannoy, M. E., Quintana, D. D., & Simpkins, J. W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00092 · Cited by 17
Metadata
- Authors
- Trevor, J. L., & Deshane, J. S.
- Venue
- Allergy
- Publisher
- Wiley
- Published
- 2014-04-29
- Volume
- 69
- Issue
- 7
- Pages
- 817-827
- ISSN
- 0105-4538 (ISSN-L)
- 1398-9995
- OpenAlex
- W2057930810
- Cited by
- 130
- References
- 6
- FWCI
- 9.33
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Refractory asthma: mechanisms, targets, and therapy. https://app.cochat.ai/papers/10.1111/all.12412
- The paper
- Trevor, J. L., & Deshane, J. S. (2014). Refractory asthma: mechanisms, targets, and therapy. Allergy. https://doi.org/10.1111/all.12412
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.